tiprankstipranks
Trending News
More News >
Swiss Re (SSREY)
OTHER OTC:SSREY
Advertisement

Swiss Re (SSREY) AI Stock Analysis

Compare
70 Followers

Top Page

SSREY

Swiss Re

(OTC:SSREY)

Rating:73Outperform
Price Target:
Swiss Re is positioned moderately well with a solid financial foundation and positive technical indicators. Strengths include strong profitability and a reasonable valuation. The earnings call highlights a robust outlook, despite revenue contraction and external challenges. The overall score reflects a balanced view of strengths and potential risks.

Swiss Re (SSREY) vs. SPDR S&P 500 ETF (SPY)

Swiss Re Business Overview & Revenue Model

Company DescriptionSwiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. The Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland.
How the Company Makes MoneySwiss Re makes money primarily through its reinsurance operations, where it provides insurance coverage to other insurance companies for risks they cannot or do not want to bear alone. Revenue is generated by charging premiums for these reinsurance policies. The Corporate Solutions segment contributes to earnings by offering insurance products tailored to the specific needs of corporations, including property and casualty, financial, and specialty lines. Additionally, Swiss Re manages portfolios of life insurance policies through its Life Capital segment, earning income from premiums and investment returns on assets under management. The company's financial performance is also influenced by its investment activities, where it invests the premiums collected into a diversified portfolio of assets, generating investment income. Strategic partnerships with other insurance companies and participation in global insurance syndicates further support Swiss Re's revenue streams.

Swiss Re Earnings Call Summary

Earnings Call Date:Aug 14, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 14, 2025
Earnings Call Sentiment Neutral
Swiss Re's earnings call highlights strong financial performance and disciplined cost management, with significant progress in P&C and investment results. However, challenges persist with declining insurance revenue and negative experience variance in Life & Health Re, as well as pressure on P&C rates.
Q2-2025 Updates
Positive Updates
Strong Net Income and ROE
Swiss Re reported a strong net income of USD 2.6 billion for the first half of 2025, resulting in an annualized ROE of 23%.
Resilient P&C Business
P&C Re's new business CSM of USD 2.2 billion in the first 6 months of the year is unchanged from the same period a year ago, showing solid performance despite market challenges.
Cost Reduction Progress
The company is on track to reduce its cost run rate by around USD 100 million this year, contributing to the overall target of USD 300 million by 2027.
Improved Combined Ratios
P&C Re's combined ratio for the first half was 81.1% compared to a target of 85%, and Corporate Solutions achieved 88.2% against a target of less than 91%.
Strong Investment Results
The return on investment was 4.1%, slightly ahead of last year's 4%, driven by realized gains and healthy recurring income.
Negative Updates
Decline in Insurance Revenue
Group's insurance revenue amounted to USD 20.9 billion in the first half, down from USD 22.2 billion last year, driven by the termination of transactions and nonrenewals.
Negative Experience Variance in Life & Health Re
Experience variance and other amounted to a negative USD 197 million, reflecting selective assumption updates in onerous business and volume updates.
Pressure on P&C Rates
Despite some positive developments, there is pressure on rates across P&C business, with some rate reductions observed.
Challenges in Small Life & Health Portfolios
Smaller portfolios in Life & Health continue to present challenges, with experience lagging expectations and requiring assumption updates.
Company Guidance
During Swiss Re's Half Year 2025 Results Conference Call, the company reported a strong net income of USD 2.6 billion for the first half, with an annualized ROE of 23%. The company achieved 60% of its full-year net income target of over USD 4.4 billion, largely driven by a robust underwriting performance in its P&C businesses, which benefited from a relatively calm second quarter with respect to large losses. The P&C Re business saw a nominal reserve release of around USD 250 million and a first-half combined ratio of 81.1%, well below the 85% target. Meanwhile, Life & Health Re reported a net income of USD 839 million, slightly above the pro-rated target. Swiss Re maintained its focus on underwriting discipline and cost management, targeting a reduction in its cost run rate by around USD 100 million in 2025, contributing to an overall target of USD 300 million by 2027. The company also highlighted a solid investment result with an ROI of 4.1% and estimated a Group SST ratio of 264% as of July 2025, up by 7 points since the beginning of the year.

Swiss Re Financial Statement Overview

Summary
Swiss Re maintains strong profitability margins and effective cash generation. However, a sharp decline in revenue and moderate reliance on debt pose concerns. The company's ability to generate free cash flow supports financial stability, but improvements in revenue growth and leveraging assets for optimal equity use are necessary.
Income Statement
65
Positive
Swiss Re shows a mixed performance on its income statement. The Gross Profit Margin is 100% due to revenue and cost being essentially the same, indicating a lack of traditional cost of goods sold. The Net Profit Margin for 2024 is approximately 37.14%, which is strong, although the Revenue Growth Rate shows a significant drop of about 80.62% from 2023 to 2024, indicating a contraction in revenue. The EBIT Margin for 2024 is 0% due to EBIT being zero, but the EBITDA Margin is robust at 48.91%, highlighting strong operational cash flows before interest, tax, depreciation, and amortization.
Balance Sheet
72
Positive
The balance sheet reflects a stable financial structure with a Debt-to-Equity Ratio of 0.31 in 2024, indicating moderate leverage. Return on Equity (ROE) is strong at 14.02%, reflecting efficient use of equity to generate profit. However, the Equity Ratio stands at 18.16%, suggesting a high reliance on liabilities to fund assets, which could pose risks if liabilities increase significantly.
Cash Flow
70
Positive
Swiss Re's cash flow statement indicates a decline in Operating Cash Flow from 2023 to 2024 by approximately 23.37%, but the Free Cash Flow remains positive at 3.13 billion in 2024. The Operating Cash Flow to Net Income Ratio is 0.97, showing good cash conversion from income. The Free Cash Flow to Net Income Ratio is 0.97, indicating effective cash generation relative to net income.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue8.72B49.73B46.04B46.74B43.34B
Gross Profit8.72B49.46B46.04B46.74B43.34B
EBITDA4.27B-23.00M1.64B-573.00M115.00M
Net Income3.24B3.21B472.00M1.44B-878.00M
Balance Sheet
Total Assets127.23B179.58B170.68B181.57B182.62B
Cash, Cash Equivalents and Short-Term Investments88.64B88.38B85.61B4.15B4.70B
Total Debt7.26B9.82B11.04B11.19B11.74B
Total Liabilities103.99B163.21B157.87B10.32B11.58B
Stockholders Equity23.11B16.15B12.70B23.57B27.14B
Cash Flow
Free Cash Flow3.13B4.09B2.93B4.10B5.39B
Operating Cash Flow3.13B4.09B2.93B4.10B5.39B
Investing Cash Flow-407.00M-362.00M-2.34B-2.14B-7.72B
Financing Cash Flow-2.97B-3.22B-1.24B-2.10B-2.50B

Swiss Re Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price44.51
Price Trends
50DMA
45.06
Negative
100DMA
44.43
Positive
200DMA
41.08
Positive
Market Momentum
MACD
-0.31
Positive
RSI
45.12
Neutral
STOCH
33.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSREY, the sentiment is Neutral. The current price of 44.51 is below the 20-day moving average (MA) of 45.26, below the 50-day MA of 45.06, and above the 200-day MA of 41.08, indicating a neutral trend. The MACD of -0.31 indicates Positive momentum. The RSI at 45.12 is Neutral, neither overbought nor oversold. The STOCH value of 33.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SSREY.

Swiss Re Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
$11.33B6.1418.75%0.66%23.19%-22.42%
82
Outperform
$2.43B6.4715.86%28.86%-11.22%
73
Outperform
$47.99B13.8817.36%4.17%-1.26%
72
Outperform
$14.26B17.715.52%2.36%10.40%-71.67%
68
Neutral
$17.80B11.949.89%3.74%9.69%1.17%
67
Neutral
$12.77B16.817.07%1.87%1.53%-10.27%
66
Neutral
$2.19B21.124.82%-4.56%-55.48%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SSREY
Swiss Re
44.51
11.41
34.47%
EG
Everest Group
339.58
-31.18
-8.41%
RGA
Reinsurance Group
192.22
-13.65
-6.63%
RNR
Renaissancere Holdings
239.96
-14.55
-5.72%
SPNT
SiriusPoint
18.97
4.95
35.31%
HG
Hamilton Insurance Group, Ltd. Class B
24.01
5.29
28.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 20, 2025